speb/financial-data huggingface dataset:
BCRX cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: -70044000.00
BCRX cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: -70044000.00
BCRX income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -19066000.00
BCRX cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: -7072000.00
BCRX balance_sheet (quarterly, 2025-06-30) — Net PPE: 20003000.00
BCRX cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -179000.00
BCRX balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: -421594000.00
BCRX income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 32631000.00
BCRX income_statement (quarterly, 2025-06-30) — Normalized Income: 8404440.33
BCRX cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 41302000.00
BCRX income_statement (quarterly, 2025-06-30) — Operating Income: 29786000.00
BCRX income_statement (quarterly, 2025-06-30) — Operating Revenue: 163353000.00
BCRX balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 209905000.00
BCRX balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 12541000.00
BCRX balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 59449000.00
BCRX balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: 1646000.00
BCRX income_statement (quarterly, 2025-06-30) — Other Income Expense: -4234000.00
BCRX balance_sheet (quarterly, 2025-06-30) — Other Inventories: -22205000.00
BCRX cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 14678000.00
BCRX balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 28622000.00
BCRX balance_sheet (quarterly, 2025-06-30) — Other Properties: 20003000.00
BCRX balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 172005000.00
BCRX income_statement (quarterly, 2025-06-30) — Other Special Charges: 4171000.00
BCRX balance_sheet (quarterly, 2025-06-30) — Payables: 8589000.00
BCRX balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 115703000.00
BCRX balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 0.00
BCRX income_statement (quarterly, 2025-06-30) — Pretax Income: 6486000.00
BCRX cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 3421000.00
BCRX cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -29341000.00
BCRX cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -179000.00
BCRX balance_sheet (quarterly, 2025-06-30) — Raw Materials: 7252000.00
BCRX balance_sheet (quarterly, 2025-06-30) — Receivables: 91177000.00
BCRX income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 2798000.00
BCRX income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 329000.00
BCRX cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -70044000.00
BCRX income_statement (quarterly, 2025-06-30) — Research And Development: 43386000.00
BCRX balance_sheet (quarterly, 2025-06-30) — Restricted Cash: 492000.00
BCRX balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -1764923000.00
BCRX cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 58647000.00
BCRX income_statement (quarterly, 2025-06-30) — Selling General And Administration: 87383000.00
BCRX balance_sheet (quarterly, 2025-06-30) — Share Issued: 209905000.00
BCRX income_statement (quarterly, 2025-06-30) — Special Income Charges: -4171000.00
BCRX cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 21304000.00
BCRX balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: -421594000.00
BCRX balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: -421594000.00
BCRX income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: -914559.67
BCRX income_statement (quarterly, 2025-06-30) — Tax Provision: 1401000.00
BCRX income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.22
BCRX balance_sheet (quarterly, 2025-06-30) — Total Assets: 457188000.00
BCRX balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 269042000.00
BCRX balance_sheet (quarterly, 2025-06-30) — Total Debt: 703176000.00
BCRX balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: -421594000.00
BCRX income_statement (quarterly, 2025-06-30) — Total Expenses: 133567000.00
BCRX balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 878782000.00
BCRX balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 58726000.00
BCRX balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 701622000.00
BCRX income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: 29786000.00
BCRX income_statement (quarterly, 2025-06-30) — Total Unusual Items: -4234000.00
BCRX income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: -4234000.00
BCRX balance_sheet (quarterly, 2025-06-30) — Work In Process: 15943000.00
BCRX balance_sheet (quarterly, 2025-06-30) — Working Capital: 221302000.00
BCRX income_statement (quarterly, 2025-09-30) — +Operating Expense: 127617000.00
BCRX income_statement (quarterly, 2025-09-30) — +Total Revenue: 159395000.00
BCRX balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 5567000.00
BCRX balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 91325000.00
BCRX balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 1360890000.00
BCRX cash_flow (quarterly, 2025-09-30) — Amortization Of Securities: -707000.00
BCRX cash_flow (quarterly, 2025-09-30) — Asset Impairment Charge: 6548000.00
BCRX balance_sheet (quarterly, 2025-09-30) — Assets Held For Sale Current: 29173000.00
BCRX income_statement (quarterly, 2025-09-30) — Basic Average Shares: 210176000.00
BCRX income_statement (quarterly, 2025-09-30) — Basic EPS: 0.06
BCRX cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 89925000.00
BCRX cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -1344000.00
BCRX balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 11950000.00
BCRX balance_sheet (quarterly, 2025-09-30) — Capital Stock: 2105000.00
BCRX balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 84078000.00
BCRX balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 212873000.00
BCRX cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -58814000.00
BCRX cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: 13572000.00
BCRX cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 41624000.00
BCRX cash_flow (quarterly, 2025-09-30) — Change In Inventory: -1692000.00
BCRX cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: -18319000.00
BCRX cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 24576000.00
BCRX cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: -5918000.00
BCRX cash_flow (quarterly, 2025-09-30) — Change In Receivables: -17000.00
BCRX cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -1370000.00
BCRX balance_sheet (quarterly, 2025-09-30) — Common Stock: 2105000.00
BCRX balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: -387889000.00
BCRX cash_flow (quarterly, 2025-09-30) — Common Stock Issuance: 21000.00
BCRX income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 2187000.00
BCRX balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 118778000.00
BCRX balance_sheet (quarterly, 2025-09-30) — Current Assets: 355684000.00
BCRX balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 1783000.00
BCRX balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 1783000.00
BCRX balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 190237000.00
BCRX cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 335000.00
BCRX cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 335000.00
BCRX income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 219885000.00
BCRX income_statement (quarterly, 2025-09-30) — Diluted EPS: 0.06
BCRX income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 12899000.00
BCRX income_statement (quarterly, 2025-09-30) — EBIT: 31791000.00
BCRX income_statement (quarterly, 2025-09-30) — EBITDA: 32126000.00
BCRX cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: -468000.00
BCRX cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -58814000.00
BCRX cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 40280000.00
BCRX income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: 35000.00
BCRX balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: 1140000.00
BCRX balance_sheet (quarterly, 2025-09-30) — Gross PPE: 19236000.00
BCRX income_statement (quarterly, 2025-09-30) — Gross Profit: 157208000.00
BCRX income_statement (quarterly, 2025-09-30) — Interest Expense: 19661000.00
BCRX income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 19661000.00
BCRX income_statement (quarterly, 2025-09-30) — Interest Income: 2238000.00
BCRX income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 2238000.00
BCRX balance_sheet (quarterly, 2025-09-30) — Inventory: 5232000.00
BCRX balance_sheet (quarterly, 2025-09-30) — Invested Capital: 245584000.00
BCRX cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: 13572000.00
BCRX balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 39669000.00
BCRX cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 21000.00
BCRX balance_sheet (quarterly, 2025-09-30) — Liabilities Heldfor Sale Non Current: 436000.00
BCRX balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 10167000.00
BCRX balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 633473000.00
BCRX balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 643640000.00
BCRX cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -46852000.00
BCRX cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 21000.00
BCRX balance_sheet (quarterly, 2025-09-30) — Net Debt: 549395000.00
BCRX income_statement (quarterly, 2025-09-30) — Net Income: 12899000.00
BCRX income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 12899000.00
BCRX income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 12899000.00
BCRX income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 12899000.00
BCRX income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 12899000.00
BCRX cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 12899000.00
BCRX income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 12899000.00
BCRX income_statement (quarterly, 2025-09-30) — Net Interest Income: -17423000.00
BCRX cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: 14366000.00
BCRX cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: -46852000.00
BCRX cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: -46852000.00
BCRX income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -17423000.00
BCRX cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: -14630000.00
BCRX balance_sheet (quarterly, 2025-09-30) — Net PPE: 19236000.00
BCRX cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -1344000.00
BCRX balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: -387889000.00
BCRX income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 34831000.00
BCRX income_statement (quarterly, 2025-09-30) — Normalized Income: 15035950.00
BCRX cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 41624000.00
BCRX cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: 2190000.00
BCRX income_statement (quarterly, 2025-09-30) — Operating Income: 29591000.00
BCRX income_statement (quarterly, 2025-09-30) — Operating Revenue: 159395000.00
BCRX balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 210521833.00
BCRX balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 16502000.00
BCRX balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 64109000.00
BCRX balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: 1140000.00
BCRX income_statement (quarterly, 2025-09-30) — Other Income Expense: -38000.00
BCRX cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 3128000.00
BCRX balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 31835000.00
BCRX income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 2667000.00
BCRX balance_sheet (quarterly, 2025-09-30) — Other Properties: 19236000.00
BCRX balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 128795000.00
BCRX income_statement (quarterly, 2025-09-30) — Other Special Charges: 2740000.00
BCRX balance_sheet (quarterly, 2025-09-30) — Payables: 5567000.00
BCRX balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 124345000.00
BCRX balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 0.00
BCRX income_statement (quarterly, 2025-09-30) — Pretax Income: 12130000.00
BCRX cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 2647000.00
BCRX cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -58634000.00
BCRX cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -1344000.00
BCRX balance_sheet (quarterly, 2025-09-30) — Receivables: 91325000.00
BCRX income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 2187000.00
BCRX income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 335000.00
BCRX cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -46852000.00
BCRX income_statement (quarterly, 2025-09-30) — Research And Development: 44603000.00
BCRX balance_sheet (quarterly, 2025-09-30) — Restricted Cash: 579000.00
BCRX balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -1752024000.00
BCRX cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 73000000.00
BCRX income_statement (quarterly, 2025-09-30) — Selling General And Administration: 83014000.00
BCRX balance_sheet (quarterly, 2025-09-30) — Share Issued: 210521833.00
BCRX income_statement (quarterly, 2025-09-30) — Special Income Charges: -2740000.00
BCRX cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 18601000.00
BCRX balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: -387889000.00
BCRX balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: -387889000.00
BCRX income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: -568050.00
BCRX income_statement (quarterly, 2025-09-30) — Tax Provision: -769000.00
BCRX income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.21
BCRX balance_sheet (quarterly, 2025-09-30) — Total Assets: 446424000.00
BCRX balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 245584000.00
BCRX balance_sheet (quarterly, 2025-09-30) — Total Debt: 645423000.00
BCRX balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: -387889000.00
BCRX income_statement (quarterly, 2025-09-30) — Total Expenses: 129804000.00
BCRX balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 834313000.00
BCRX balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 90740000.00
BCRX balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 644076000.00
BCRX income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: 29591000.00
BCRX income_statement (quarterly, 2025-09-30) — Total Unusual Items: -2705000.00
BCRX income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: -2705000.00
BCRX balance_sheet (quarterly, 2025-09-30) — Working Capital: 165447000.00
BCRX income_statement (annual, 2025-12-31) — +Operating Expense: 514773000.00
BCRX income_statement (quarterly, 2025-12-31) — +Operating Expense: 136648000.00
BCRX income_statement (annual, 2025-12-31) — +Total Revenue: 874837000.00
BCRX income_statement (quarterly, 2025-12-31) — +Total Revenue: 406555000.00
BCRX balance_sheet (annual, 2025-12-31) — Accounts Payable: 15826000.00
BCRX balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 15826000.00
BCRX balance_sheet (annual, 2025-12-31) — Accounts Receivable: 106818000.00
BCRX balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 106818000.00
BCRX balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -9394000.00
BCRX balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -9394000.00
BCRX balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 1384857000.00
BCRX balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 1384857000.00
BCRX cash_flow (annual, 2025-12-31) — Amortization Of Securities: -4331000.00
BCRX cash_flow (quarterly, 2025-12-31) — Amortization Of Securities: -1091000.00
BCRX cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 985000.00
BCRX cash_flow (quarterly, 2025-12-31) — Asset Impairment Charge: -71000.00
BCRX income_statement (annual, 2025-12-31) — Basic Average Shares: 209893000.00
BCRX income_statement (quarterly, 2025-12-31) — Basic Average Shares: 210969000.00
BCRX income_statement (annual, 2025-12-31) — Basic EPS: 1.26
BCRX income_statement (quarterly, 2025-12-31) — Basic EPS: 1.17
BCRX cash_flow (annual, 2025-12-31) — Beginning Cash Position: 106323000.00
BCRX cash_flow (annual, 2025-12-31) — Capital Expenditure: -2468000.00
BCRX cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -802000.00
BCRX balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 11641000.00
BCRX balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 11641000.00
BCRX balance_sheet (annual, 2025-12-31) — Capital Stock: 2131000.00
BCRX balance_sheet (quarterly, 2025-12-31) — Capital Stock: 2131000.00
BCRX balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 89736000.00
BCRX balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 89736000.00
BCRX balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 274747000.00
BCRX balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 274747000.00
BCRX cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -349931000.00
BCRX cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -217960000.00
BCRX cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -13694000.00
BCRX cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -83488000.00
BCRX cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 347369000.00
BCRX cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 291960000.00
BCRX cash_flow (annual, 2025-12-31) — Change In Account Payable: 57802000.00
BCRX cash_flow (quarterly, 2025-12-31) — Change In Account Payable: 35361000.00
BCRX cash_flow (annual, 2025-12-31) — Change In Inventory: -1639000.00
BCRX cash_flow (quarterly, 2025-12-31) — Change In Inventory: -515000.00
BCRX cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: -68428000.00
BCRX cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: -13188000.00
BCRX cash_flow (annual, 2025-12-31) — Change In Payable: 57802000.00
BCRX cash_flow (quarterly, 2025-12-31) — Change In Payable: 35361000.00
BCRX cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 57802000.00
BCRX cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 35361000.00
BCRX cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: -7827000.00
BCRX cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: -1937000.00
BCRX cash_flow (annual, 2025-12-31) — Change In Receivables: -36806000.00
BCRX cash_flow (quarterly, 2025-12-31) — Change In Receivables: -15494000.00
BCRX cash_flow (annual, 2025-12-31) — Change In Working Capital: -56898000.00
BCRX cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 4227000.00
BCRX cash_flow (annual, 2025-12-31) — Changes In Cash: -16256000.00
BCRX balance_sheet (annual, 2025-12-31) — Common Stock: 2131000.00
BCRX balance_sheet (quarterly, 2025-12-31) — Common Stock: 2131000.00
BCRX balance_sheet (annual, 2025-12-31) — Common Stock Equity: -119153000.00
BCRX balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: -119153000.00
BCRX cash_flow (annual, 2025-12-31) — Common Stock Issuance: 59000.00
BCRX cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 23000.00
BCRX balance_sheet (annual, 2025-12-31) — Construction In Progress: 0.00
BCRX balance_sheet (quarterly, 2025-12-31) — Construction In Progress: 0.00
BCRX income_statement (annual, 2025-12-31) — Cost Of Revenue: 19075000.00
BCRX income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 9522000.00
BCRX balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 39964000.00
BCRX balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 39964000.00
BCRX balance_sheet (annual, 2025-12-31) — Current Assets: 404346000.00
BCRX balance_sheet (quarterly, 2025-12-31) — Current Assets: 404346000.00
BCRX balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 1629000.00
BCRX balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 1629000.00
BCRX balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 1629000.00
BCRX balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 1629000.00
BCRX balance_sheet (annual, 2025-12-31) — Current Liabilities: 196066000.00
BCRX balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 196066000.00
BCRX balance_sheet (annual, 2025-12-31) — Current Provisions: 26632000.00
BCRX balance_sheet (quarterly, 2025-12-31) — Current Provisions: 26632000.00
BCRX cash_flow (annual, 2025-12-31) — Depreciation: 1389000.00
BCRX cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 1389000.00
BCRX cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 394000.00
BCRX cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 1389000.00
BCRX cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 394000.00
BCRX income_statement (annual, 2025-12-31) — Diluted Average Shares: 218581000.00
BCRX income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 219263000.00
BCRX income_statement (annual, 2025-12-31) — Diluted EPS: 1.21
BCRX income_statement (quarterly, 2025-12-31) — Diluted EPS: 1.12
BCRX income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 263861000.00
BCRX income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 245845000.00
BCRX income_statement (annual, 2025-12-31) — EBIT: 346263000.00
BCRX income_statement (quarterly, 2025-12-31) — EBIT: 262152000.00
BCRX income_statement (annual, 2025-12-31) — EBITDA: 347652000.00
BCRX income_statement (quarterly, 2025-12-31) — EBITDA: 262546000.00
BCRX cash_flow (annual, 2025-12-31) — Earnings Losses From Equity Investments: 17548000.00
BCRX cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: 1270000.00
BCRX cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: -72000.00
BCRX cash_flow (annual, 2025-12-31) — End Cash Position: 91337000.00
BCRX cash_flow (annual, 2025-12-31) — Financing Cash Flow: -349931000.00
BCRX cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -217960000.00
BCRX balance_sheet (annual, 2025-12-31) — Finished Goods: 7275000.00
BCRX balance_sheet (quarterly, 2025-12-31) — Finished Goods: 7275000.00
BCRX cash_flow (annual, 2025-12-31) — Free Cash Flow: 344901000.00
BCRX cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 291158000.00
BCRX cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: -4863000.00
BCRX cash_flow (quarterly, 2025-12-31) — Gain Loss On Investment Securities: -4313000.00
BCRX cash_flow (annual, 2025-12-31) — Gain Loss On Sale Of Business: -3566000.00
BCRX income_statement (annual, 2025-12-31) — Gain On Sale Of Security: -152000.00
BCRX income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: -125000.00
BCRX balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 38000.00
BCRX balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 38000.00
BCRX balance_sheet (annual, 2025-12-31) — Gross PPE: 28380000.00
BCRX balance_sheet (quarterly, 2025-12-31) — Gross PPE: 28380000.00
BCRX income_statement (annual, 2025-12-31) — Gross Profit: 855762000.00
BCRX income_statement (quarterly, 2025-12-31) — Gross Profit: 397033000.00
BCRX income_statement (annual, 2025-12-31) — Interest Expense: 78872000.00
BCRX income_statement (quarterly, 2025-12-31) — Interest Expense: 14135000.00
BCRX income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 78872000.00
BCRX income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 14135000.00
BCRX income_statement (annual, 2025-12-31) — Interest Income: 10668000.00
BCRX income_statement (quarterly, 2025-12-31) — Interest Income: 2890000.00
BCRX income_statement (annual, 2025-12-31) — Interest Income Non Operating: 10668000.00
BCRX income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 2890000.00
BCRX cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 23735000.00
BCRX balance_sheet (annual, 2025-12-31) — Inventories Adjustments Allowances: -775000.00
BCRX balance_sheet (quarterly, 2025-12-31) — Inventories Adjustments Allowances: -775000.00
BCRX balance_sheet (annual, 2025-12-31) — Inventory: 5398000.00
BCRX balance_sheet (quarterly, 2025-12-31) — Inventory: 5398000.00
BCRX balance_sheet (annual, 2025-12-31) — Invested Capital: 308080000.00
BCRX balance_sheet (quarterly, 2025-12-31) — Invested Capital: 308080000.00
BCRX cash_flow (annual, 2025-12-31) — Investing Cash Flow: -13694000.00
BCRX cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -83488000.00
BCRX balance_sheet (annual, 2025-12-31) — Investments And Advances: 61164000.00
BCRX balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 61164000.00
BCRX cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 59000.00
BCRX cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 23000.00
BCRX cash_flow (annual, 2025-12-31) — Issuance Of Debt: 0.00
BCRX balance_sheet (annual, 2025-12-31) — Leases: 10437000.00
BCRX balance_sheet (quarterly, 2025-12-31) — Leases: 10437000.00
BCRX balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 10012000.00
BCRX balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 10012000.00
BCRX balance_sheet (annual, 2025-12-31) — Long Term Debt: 427233000.00
BCRX balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 427233000.00
BCRX balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 437245000.00
BCRX balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 437245000.00
BCRX cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 0.00
BCRX cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -301989000.00
BCRX cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -184577000.00
BCRX balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 2147000.00
BCRX balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 2147000.00
BCRX cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: -6183000.00
BCRX cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 59000.00
BCRX cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 23000.00
BCRX balance_sheet (annual, 2025-12-31) — Net Debt: 337497000.00
BCRX balance_sheet (quarterly, 2025-12-31) — Net Debt: 337497000.00
BCRX income_statement (annual, 2025-12-31) — Net Income: 263861000.00
BCRX income_statement (quarterly, 2025-12-31) — Net Income: 245845000.00
BCRX income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 263861000.00
BCRX income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 245845000.00
BCRX income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 263861000.00
BCRX income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 245845000.00
BCRX income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 263861000.00
BCRX income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 245845000.00
BCRX income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 263861000.00
BCRX income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 245845000.00
BCRX cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 263861000.00
BCRX cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 245845000.00
BCRX income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 263861000.00
BCRX income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 245845000.00
BCRX income_statement (annual, 2025-12-31) — Net Interest Income: -68204000.00
BCRX income_statement (quarterly, 2025-12-31) — Net Interest Income: -11245000.00
BCRX cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: -5593000.00
BCRX cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: -76503000.00
BCRX cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: -301989000.00
BCRX cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -184577000.00
BCRX cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: -301989000.00
BCRX cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -184577000.00
BCRX income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -68204000.00
BCRX income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -11245000.00
BCRX cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -57116000.00
BCRX cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: -34063000.00
BCRX cash_flow (annual, 2025-12-31) — Net Other Investing Changes: 550000.00
BCRX cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: 0.00
BCRX balance_sheet (annual, 2025-12-31) — Net PPE: 18986000.00
BCRX balance_sheet (quarterly, 2025-12-31) — Net PPE: 18986000.00
BCRX cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -2468000.00
BCRX cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -802000.00
BCRX balance_sheet (annual, 2025-12-31) — Net Tangible Assets: -119153000.00
BCRX balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: -119153000.00
BCRX income_statement (annual, 2025-12-31) — Normalized EBITDA: 365136000.00
BCRX income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 273092000.00
BCRX income_statement (annual, 2025-12-31) — Normalized Income: 281170160.00
BCRX income_statement (quarterly, 2025-12-31) — Normalized Income: 256298643.78
BCRX cash_flow (annual, 2025-12-31) — Operating Cash Flow: 347369000.00
BCRX cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 291960000.00
BCRX cash_flow (annual, 2025-12-31) — Operating Gains Losses: 26451000.00
BCRX cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: 20090000.00
BCRX income_statement (annual, 2025-12-31) — Operating Income: 340989000.00
BCRX income_statement (quarterly, 2025-12-31) — Operating Income: 260385000.00
BCRX income_statement (annual, 2025-12-31) — Operating Revenue: 874837000.00
BCRX income_statement (quarterly, 2025-12-31) — Operating Revenue: 406555000.00
BCRX balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 213059576.00
BCRX balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 213059576.00
BCRX balance_sheet (annual, 2025-12-31) — Other Current Assets: 17182000.00
BCRX balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 17182000.00
BCRX balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 52198000.00
BCRX balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 52198000.00
BCRX balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: 38000.00
BCRX balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: 38000.00
BCRX income_statement (annual, 2025-12-31) — Other Income Expense: -5394000.00
BCRX income_statement (quarterly, 2025-12-31) — Other Income Expense: -1123000.00
BCRX balance_sheet (annual, 2025-12-31) — Other Inventories: -23990000.00
BCRX balance_sheet (quarterly, 2025-12-31) — Other Inventories: -23990000.00
BCRX cash_flow (annual, 2025-12-31) — Other Non Cash Items: 30846000.00
BCRX cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: -1227000.00
BCRX balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 29662000.00
BCRX balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 29662000.00
BCRX income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: 12090000.00
BCRX income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 9423000.00
BCRX balance_sheet (annual, 2025-12-31) — Other Payable: 8960000.00
BCRX balance_sheet (quarterly, 2025-12-31) — Other Payable: 8960000.00
BCRX balance_sheet (annual, 2025-12-31) — Other Properties: 15796000.00
BCRX balance_sheet (quarterly, 2025-12-31) — Other Properties: 15796000.00
BCRX balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 185011000.00
BCRX balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 185011000.00
BCRX income_statement (annual, 2025-12-31) — Other Special Charges: 17332000.00
BCRX income_statement (quarterly, 2025-12-31) — Other Special Charges: 10421000.00
BCRX balance_sheet (annual, 2025-12-31) — Payables: 24786000.00
BCRX balance_sheet (quarterly, 2025-12-31) — Payables: 24786000.00
BCRX balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 64750000.00
BCRX balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 64750000.00
BCRX balance_sheet (annual, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 50857000.00
BCRX balance_sheet (quarterly, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 50857000.00
BCRX balance_sheet (annual, 2025-12-31) — Preferred Stock: 0.00
BCRX balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 0.00
BCRX income_statement (annual, 2025-12-31) — Pretax Income: 267391000.00
BCRX income_statement (quarterly, 2025-12-31) — Pretax Income: 248017000.00
BCRX cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: 9115000.00
BCRX cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: 657000.00
BCRX balance_sheet (annual, 2025-12-31) — Properties: 0.00
BCRX balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
BCRX cash_flow (annual, 2025-12-31) — Purchase Of Business: -6183000.00
BCRX cash_flow (annual, 2025-12-31) — Purchase Of Investment: -262240000.00
BCRX cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: -125503000.00
BCRX cash_flow (annual, 2025-12-31) — Purchase Of PPE: -2468000.00
BCRX cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -802000.00
BCRX balance_sheet (annual, 2025-12-31) — Raw Materials: 9997000.00
BCRX balance_sheet (quarterly, 2025-12-31) — Raw Materials: 9997000.00
BCRX balance_sheet (annual, 2025-12-31) — Receivables: 106818000.00
BCRX balance_sheet (quarterly, 2025-12-31) — Receivables: 106818000.00
BCRX income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 19075000.00
BCRX income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 9522000.00
BCRX income_statement (annual, 2025-12-31) — Reconciled Depreciation: 1389000.00
BCRX income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 394000.00
BCRX cash_flow (annual, 2025-12-31) — Repayment Of Debt: -301989000.00
BCRX cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -184577000.00
BCRX income_statement (annual, 2025-12-31) — Research And Development: 166126000.00
BCRX income_statement (quarterly, 2025-12-31) — Research And Development: 40867000.00
BCRX balance_sheet (annual, 2025-12-31) — Restricted Cash: 201000.00
BCRX balance_sheet (quarterly, 2025-12-31) — Restricted Cash: 201000.00
BCRX balance_sheet (annual, 2025-12-31) — Retained Earnings: -1506179000.00
BCRX balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -1506179000.00
BCRX cash_flow (annual, 2025-12-31) — Sale Of Investment: 256647000.00
BCRX cash_flow (quarterly, 2025-12-31) — Sale Of Investment: 49000000.00
BCRX income_statement (annual, 2025-12-31) — Selling General And Administration: 348647000.00
BCRX income_statement (quarterly, 2025-12-31) — Selling General And Administration: 95781000.00
BCRX balance_sheet (annual, 2025-12-31) — Share Issued: 213059576.00
BCRX balance_sheet (quarterly, 2025-12-31) — Share Issued: 213059576.00
BCRX income_statement (annual, 2025-12-31) — Special Income Charges: -17332000.00
BCRX income_statement (quarterly, 2025-12-31) — Special Income Charges: -10421000.00
BCRX cash_flow (annual, 2025-12-31) — Stock Based Compensation: 85066000.00
BCRX cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 23793000.00
BCRX balance_sheet (annual, 2025-12-31) — Stockholders Equity: -119153000.00
BCRX balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: -119153000.00
BCRX balance_sheet (annual, 2025-12-31) — Tangible Book Value: -119153000.00
BCRX balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: -119153000.00
BCRX income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: -174840.00
BCRX income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: -92356.22
BCRX income_statement (annual, 2025-12-31) — Tax Provision: 3530000.00
BCRX income_statement (quarterly, 2025-12-31) — Tax Provision: 2172000.00
BCRX income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.01
BCRX income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.01
BCRX balance_sheet (annual, 2025-12-31) — Total Assets: 514158000.00
BCRX balance_sheet (quarterly, 2025-12-31) — Total Assets: 514158000.00
BCRX balance_sheet (annual, 2025-12-31) — Total Capitalization: 308080000.00
BCRX balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 308080000.00
BCRX balance_sheet (annual, 2025-12-31) — Total Debt: 438874000.00
BCRX balance_sheet (quarterly, 2025-12-31) — Total Debt: 438874000.00
BCRX balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: -119153000.00
BCRX balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: -119153000.00
BCRX income_statement (annual, 2025-12-31) — Total Expenses: 533848000.00
BCRX income_statement (quarterly, 2025-12-31) — Total Expenses: 146170000.00
BCRX balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 633311000.00
BCRX balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 633311000.00
BCRX balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 109812000.00
BCRX balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 109812000.00
BCRX balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 437245000.00
BCRX balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 437245000.00
BCRX income_statement (annual, 2025-12-31) — Total Operating Income As Reported: 340989000.00
BCRX income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: 260385000.00
BCRX income_statement (annual, 2025-12-31) — Total Unusual Items: -17484000.00
BCRX income_statement (quarterly, 2025-12-31) — Total Unusual Items: -10546000.00
BCRX income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: -17484000.00
BCRX income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -10546000.00
BCRX balance_sheet (annual, 2025-12-31) — Work In Process: 12891000.00
BCRX balance_sheet (quarterly, 2025-12-31) — Work In Process: 12891000.00
BCRX balance_sheet (annual, 2025-12-31) — Working Capital: 208280000.00
BCRX balance_sheet (quarterly, 2025-12-31) — Working Capital: 208280000.00
BCRX income_statement (quarterly, 2026-03-31) — +Operating Expense: 852634000.00
BCRX income_statement (quarterly, 2026-03-31) — +Total Revenue: 156413000.00
BCRX balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 10958000.00
BCRX balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 109272000.00
BCRX balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 1671976000.00
BCRX cash_flow (quarterly, 2026-03-31) — Amortization Of Securities: 251000.00
BCRX income_statement (quarterly, 2026-03-31) — Basic Average Shares: 242258000.00
BCRX income_statement (quarterly, 2026-03-31) — Basic EPS: -2.98
BCRX cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 91337000.00
BCRX cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -403000.00
BCRX balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 15388000.00
BCRX balance_sheet (quarterly, 2026-03-31) — Capital Stock: 2540000.00
BCRX balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 171591000.00
BCRX balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 238400000.00
BCRX cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: 412552000.00
BCRX cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -268648000.00
BCRX cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -61791000.00
BCRX cash_flow (quarterly, 2026-03-31) — Change In Inventory: -4847000.00
BCRX cash_flow (quarterly, 2026-03-31) — Change In Other Current Liabilities: -8470000.00
BCRX cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: -749000.00
BCRX cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -60395000.00
BCRX cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: 3532000.00
BCRX cash_flow (quarterly, 2026-03-31) — Change In Receivables: -474000.00
BCRX cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -71403000.00
BCRX cash_flow (quarterly, 2026-03-31) — Changes In Cash: 82113000.00
BCRX balance_sheet (quarterly, 2026-03-31) — Common Stock: 2540000.00
BCRX balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: -553843000.00
BCRX cash_flow (quarterly, 2026-03-31) — Common Stock Issuance: 33000.00
BCRX income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 5377000.00
BCRX balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 119398000.00
BCRX balance_sheet (quarterly, 2026-03-31) — Current Assets: 373625000.00
BCRX balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 3093000.00
BCRX balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 3093000.00
BCRX balance_sheet (quarterly, 2026-03-31) — Current Deferred Liabilities: 5409000.00
BCRX balance_sheet (quarterly, 2026-03-31) — Current Deferred Revenue: 5409000.00
BCRX balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 195391000.00
BCRX cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 461000.00
BCRX cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 461000.00
BCRX income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 242258000.00
BCRX income_statement (quarterly, 2026-03-31) — Diluted EPS: -2.98
BCRX income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -721812000.00
BCRX income_statement (quarterly, 2026-03-31) — EBIT: -701029000.00
BCRX income_statement (quarterly, 2026-03-31) — EBITDA: -700568000.00
BCRX cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: -72000.00
BCRX cash_flow (quarterly, 2026-03-31) — End Cash Position: 173378000.00
BCRX cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 412552000.00
BCRX cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -62194000.00
BCRX cash_flow (quarterly, 2026-03-31) — Gain Loss On Investment Securities: 2807000.00
BCRX income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: -225000.00
BCRX balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -368000.00
BCRX balance_sheet (quarterly, 2026-03-31) — Gross PPE: 22985000.00
BCRX income_statement (quarterly, 2026-03-31) — Gross Profit: 151036000.00
BCRX cash_flow (quarterly, 2026-03-31) — Income Tax Paid Supplemental Data: 1431000.00
BCRX income_statement (quarterly, 2026-03-31) — Interest Expense: 19779000.00
BCRX income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 19779000.00
BCRX income_statement (quarterly, 2026-03-31) — Interest Income: 2256000.00
BCRX income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 2256000.00
BCRX cash_flow (quarterly, 2026-03-31) — Interest Paid Supplemental Data: 6083000.00
BCRX balance_sheet (quarterly, 2026-03-31) — Inventory: 5985000.00
BCRX balance_sheet (quarterly, 2026-03-31) — Invested Capital: 248535000.00
BCRX cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -268648000.00
BCRX balance_sheet (quarterly, 2026-03-31) — Investments And Advances: 20569000.00
BCRX cash_flow (quarterly, 2026-03-31) — Issuance Of Capital Stock: 33000.00
BCRX cash_flow (quarterly, 2026-03-31) — Issuance Of Debt: 400000000.00
BCRX balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 12295000.00
BCRX balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 802378000.00
BCRX balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 814673000.00
BCRX cash_flow (quarterly, 2026-03-31) — Long Term Debt Issuance: 400000000.00
BCRX cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -345000.00
BCRX cash_flow (quarterly, 2026-03-31) — Net Business Purchase And Sale: -489480000.00
BCRX cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: 33000.00
BCRX balance_sheet (quarterly, 2026-03-31) — Net Debt: 630787000.00
BCRX income_statement (quarterly, 2026-03-31) — Net Income: -721812000.00
BCRX income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -721812000.00
BCRX income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -721812000.00
BCRX income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -721812000.00
BCRX income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -721812000.00
BCRX cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: -721812000.00
BCRX income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -721812000.00
BCRX income_statement (quarterly, 2026-03-31) — Net Interest Income: -17523000.00
BCRX cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: 221235000.00
BCRX cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: 399655000.00
BCRX cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: 399655000.00
BCRX income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -17523000.00
BCRX cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -6615000.00
BCRX balance_sheet (quarterly, 2026-03-31) — Net PPE: 22985000.00
BCRX cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -403000.00
BCRX balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: -553843000.00
BCRX balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 8831000.00
BCRX balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Revenue: 8831000.00
BCRX income_statement (quarterly, 2026-03-31) — Normalized EBITDA: -700343000.00
BCRX income_statement (quarterly, 2026-03-31) — Normalized Income: -721677000.00
BCRX cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -61791000.00
BCRX cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: 2807000.00
BCRX income_statement (quarterly, 2026-03-31) — Operating Income: -701598000.00
BCRX income_statement (quarterly, 2026-03-31) — Operating Revenue: 151363000.00
BCRX balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 254014000.00
BCRX balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 19114000.00
BCRX balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 56533000.00
BCRX balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: -368000.00
BCRX income_statement (quarterly, 2026-03-31) — Other Income Expense: -1687000.00
BCRX cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 711878000.00
BCRX balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 47873000.00
BCRX income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: -1462000.00